Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.

Chang, Hsuan-Yu; Hsu, Chia-Chen; Hu, Li-Fang; Chou, Chian-Ying; Chang, Yuh-Lih; Lu, Chih-Chia; Chang, Li-Jen

Chang, Hsuan-Yu; Hsu, Chia-Chen; Hu, Li-Fang; Chou, Chian-Ying; Chang, Yuh-Lih; Lu, Chih-Chia; Chang, Li-Jen.

Affiliation

Chang HY; Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsu CC; Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Hu LF; Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.
Chou CY; Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chang YL; Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.
Lu CC; Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chang LJ; Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.

Ann Med ; 56(1): 2361843, 2024 Dec.

Article de En | MEDLINE | ID: mdl-38830017

Sujet(s)
Mots clés

COVID-19; acute kidney injury; remdesivir; severe renal impairment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / AMP / Mortalité hospitalière / Alanine / Atteinte rénale aigüe / SARS-CoV-2 / Traitements médicamenteux de la COVID-19 / Débit de filtration glomérulaire / Hospitalisation Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Ann Med Sujet du journal: MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: Taïwan Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google